Latest News in the pharma Industry

Research & Development

Adding Investigational Agent Elotuzumab to Standard Treatment for Multiple Myeloma Significantly Reduced the Risk of Disease Progression

Adding Investigational Agent Elotuzumab to Standard Treatment for Multiple Myeloma Significantly Reduced the Risk of Disease Progression

3 Jun 2015

Read more 
Process uses 3-D Printing to Produce Tough but Flexible Hydrogel Structures

Process uses 3-D Printing to Produce Tough but Flexible Hydrogel Structures

2 Jun 2015

Read more 
Combination of Novartis Drugs Tafinlar and Mekinist Sshows Significant Survival Benefit in Patients with Metastatic Melanoma

Combination of Novartis Drugs Tafinlar and Mekinist Sshows Significant Survival Benefit in Patients with Metastatic Melanoma

1 Jun 2015

Read more 
Genentech’s Perjeta Regimen Helped People with HER2-Positive Early Breast Cancer Live Longer without Their Disease Returning or Getting Worse

Genentech’s Perjeta Regimen Helped People with HER2-Positive Early Breast Cancer Live Longer without Their Disease Returning or Getting Worse

1 Jun 2015

Read more 
Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumours

Lilly and AstraZeneca to Collaborate on Immuno-Oncology Combination Clinical Trial in Solid Tumours

29 May 2015

Read more 
Merck and NanoString Collaborate to Develop an Immune-Related Gene Expression Assay for Use in the Development Programme for Keytruda

Merck and NanoString Collaborate to Develop an Immune-Related Gene Expression Assay for Use in the Development Programme for Keytruda

28 May 2015

Read more 
PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting

PROCLAIM Final Trial Results to be Presented at ASCO Annual Meeting

28 May 2015

Read more 
Novartis Presents New Data on 21 Medicines and 11 Investigational Compounds at ASCO and EHA

Novartis Presents New Data on 21 Medicines and 11 Investigational Compounds at ASCO and EHA

27 May 2015

Read more 
Regeneron and Sanofi Announce Positive Topline Results from Phase III Studies with Sarilumab in Patients with RA

Regeneron and Sanofi Announce Positive Topline Results from Phase III Studies with Sarilumab in Patients with RA

26 May 2015

Read more 
BMS Receives Amended FDA Breakthrough Therapy Designation for Investigational Daclatasvir-Based Hepatitis C Regimen

BMS Receives Amended FDA Breakthrough Therapy Designation for Investigational Daclatasvir-Based Hepatitis C Regimen

26 May 2015

Read more 
Amgen to Terminate Participation in Co-development and Commercialization of Brodalumab

Amgen to Terminate Participation in Co-development and Commercialization of Brodalumab

25 May 2015

Read more 
Otonomy Reports Phase IIb Topline Data for OTO-104 in Meniere's Disease

Otonomy Reports Phase IIb Topline Data for OTO-104 in Meniere's Disease

25 May 2015

Read more